T-Cell Costimulatory Blockade in Organ Transplantation

被引:13
|
作者
Maltzman, Jonathan S. [1 ]
Turka, Laurence A. [2 ,3 ]
机构
[1] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA
[2] Massachusetts Gen Hosp, Dept Surg, Transplantat Biol Res Ctr, Boston, MA 02129 USA
[3] Harvard Univ, Sch Med, Boston, MA 02129 USA
来源
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE | 2013年 / 3卷 / 12期
关键词
RECEPTOR-ASSOCIATED FACTORS; RENAL-ALLOGRAFT REJECTION; LONG-TERM ACCEPTANCE; MONOCLONAL-ANTIBODY; CARDIAC ALLOGRAFTS; CD40; LIGAND; B-CELL; CD28; COSTIMULATION; DENDRITIC CELL; ANTIGEN; 4-1BB;
D O I
10.1101/cshperspect.a015537
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Before it became possible to derive T-cell lines and clones, initial experimentation on the activation requirements of T lymphocytes was performed on transformed cell lines, such as Jurkat. These studies, although technically correct, proved misleading as most transformed T cells can be activated by stimulation of the clonotypic T-cell receptor (TCR) alone. In contrast, once it became possible to study nontransformed T cells, it quickly became clear that TCR stimulation by itself is insufficient for optimal activation of nai ve T cells, but in fact, induces a state of anergy. It then became clear that functional activation of T cells requires not only recognition of major histocompatibility complex (MHC) and peptide by the TCR, but also requires ligation of costimulatory receptors expressed on the cell surface.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Cloning and sequencing of dog cDNA encoding the T-cell costimulatory molecule (CTLA-4)
    T. S. Khatlani
    K. Ohno
    Z. Ma
    H. Inokuma
    T. Onishi
    Immunogenetics, 2000, 51 : 79 - 81
  • [42] Blockade of CD7 expression in T cells for effective chimeric antigen receptor targeting of T-cell malignancies
    Png, Yi Tian
    Vinanica, Natasha
    Kamiya, Takahiro
    Shimasaki, Noriko
    Coustan-Smith, Elaine
    Campana, Dario
    BLOOD ADVANCES, 2017, 1 (25) : 2348 - 2360
  • [43] Stem cell transplantation as a biological therapy for peripheral T-cell lymphomas
    Abouyabis, Abeer N.
    Shenoy, Pareen J.
    Lechowicz, Mary Jo
    Flowers, Christopher R.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2011, 11 (01) : 31 - 40
  • [44] Hematopoeitic Cell Transplantation and CAR T-Cell Therapy: Complements or Competitors?
    Goldsmith, Scott R.
    Ghobadi, Armin
    DiPersio, John F.
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [45] Boosting Antitumor Response by Costimulatory Strategies Driven to 4-1BB and OX40 T-cell Receptors
    Mascarelli, Daniele E.
    Rosa, Rhubia S. M.
    Toscaro, Jessica M.
    Semionatto, Isadora F.
    Ruas, Luciana P.
    Fogagnolo, Carolinne T.
    Lima, Gabriel C.
    Bajgelman, Marcio C.
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [46] T-cell therapies for T-cell lymphoma
    Toner, Keri
    Bollard, Catherine M.
    Dave, Hema
    CYTOTHERAPY, 2019, 21 (09) : 935 - 942
  • [47] Analysis of T-Cell Receptor Repertoire in Transplantation: Fingerprint of T Cell-mediated Alloresponse
    Tian, Guangyao
    Li, Mingqian
    Lv, Guoyue
    FRONTIERS IN IMMUNOLOGY, 2022, 12
  • [48] Chimeric antigen receptor T-cell therapy for T-cell acute lymphoblastic leukemia
    Oh, Bernice L. Z.
    Vinanica, Natasha
    Wong, Desmond M. H.
    Campana, Dario
    HAEMATOLOGICA, 2024, 109 (06) : 1677 - 1688
  • [49] Untangling the Knots of Regulatory T Cell Therapy in Solid Organ Transplantation
    Orozco, Gabriel
    Gupta, Meera
    Gedaly, Roberto
    Marti, Francesc
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [50] CTLA4 Blockade Broadens the Peripheral T-Cell Receptor Repertoire
    Robert, Lidia
    Tsoi, Jennifer
    Wang, Xiaoyan
    Emerson, Ryan
    Homet, Blanca
    Chodon, Thinle
    Mok, Stephen
    Huang, Rong Rong
    Cochran, Alistair J.
    Comin-Anduix, Begona
    Koya, Richard C.
    Graeber, Thomas G.
    Robins, Harlan
    Ribas, Antoni
    CLINICAL CANCER RESEARCH, 2014, 20 (09) : 2424 - 2432